DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-264 Cr | ₹-334 Cr | ₹-414 Cr | ₹-283 Cr | ₹136 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR LAL PATHLABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-264 Cr |
| Mar2025 | ₹-334 Cr |
| Mar2024 | ₹-414 Cr |
| Mar2023 | ₹-283 Cr |
| Mar2022 | ₹136 Cr |
How is Cash Flow from Financing Activities of DR LAL PATHLABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-264 Cr | Negative | |
| Mar2025 | ₹-334 Cr | Negative | |
| Mar2024 | ₹-414 Cr | Negative | |
| Mar2023 | ₹-283 Cr | Negative | |
| Mar2022 | ₹136 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹28,261.6 Cr | -2.3% | 2.2% | 18.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹126,836.0 Cr | 0.5% | 4.6% | 20.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹106,058.0 Cr | -1.7% | 6.2% | -12.2% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹71,868.2 Cr | -1.3% | 0.2% | 24.6% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹71,477.1 Cr | 0.6% | 7% | 35.3% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹41,436.2 Cr | -0.4% | 10% | 3% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -2.3% |
2.2% |
18.3% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses